INR 1481.8
(1.28%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 327.17 Billion INR | 11.05% |
2022 | 294.63 Billion INR | 8.72% |
2021 | 271.01 Billion INR | 7.75% |
2020 | 251.51 Billion INR | 6.29% |
2019 | 236.62 Billion INR | -1.26% |
2018 | 239.63 Billion INR | 4.82% |
2017 | 228.6 Billion INR | 9.1% |
2016 | 209.53 Billion INR | 0.29% |
2015 | 208.92 Billion INR | 32.93% |
2014 | 157.17 Billion INR | 17.27% |
2013 | 134.03 Billion INR | 14.97% |
2012 | 116.57 Billion INR | 24.68% |
2011 | 93.5 Billion INR | 8.34% |
2010 | 86.3 Billion INR | 18.07% |
2009 | 73.09 Billion INR | 6.6% |
2008 | 68.56 Billion INR | 19.61% |
2007 | 57.32 Billion INR | 29.88% |
2006 | 44.13 Billion INR | 27.63% |
2005 | 34.58 Billion INR | 32.2% |
2004 | 26.16 Billion INR | 17.83% |
2003 | 22.2 Billion INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2024 Q2 | 346.55 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 327.17 Billion INR | 11.05% |
2023 Q2 | 313.77 Billion INR | 0.0% |
2023 Q4 | 327.17 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 294.63 Billion INR | 0.0% |
2022 FY | 294.63 Billion INR | 8.72% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 280.62 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2021 Q4 | 271.01 Billion INR | 0.0% |
2021 FY | 271.01 Billion INR | 7.75% |
2021 Q2 | 262.38 Billion INR | 0.0% |
2020 FY | 251.51 Billion INR | 6.29% |
2020 Q4 | 251.51 Billion INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 Q2 | 254.07 Billion INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2019 Q2 | 241.46 Billion INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 FY | 236.62 Billion INR | -1.26% |
2019 Q4 | 236.62 Billion INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 FY | 239.63 Billion INR | 4.82% |
2018 Q4 | 239.63 Billion INR | 0.0% |
2018 Q2 | 240.02 Billion INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2017 Q1 | - INR | -100.0% |
2017 FY | 228.6 Billion INR | 9.1% |
2017 Q4 | 228.6 Billion INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2017 Q2 | 225.94 Billion INR | 0.0% |
2016 Q4 | 209.53 Billion INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2016 Q2 | 217.42 Billion INR | 0.0% |
2016 FY | 209.53 Billion INR | 0.29% |
2016 Q3 | - INR | -100.0% |
2015 Q3 | - INR | -100.0% |
2015 FY | 208.92 Billion INR | 32.93% |
2015 Q1 | - INR | -100.0% |
2015 Q2 | 166.14 Billion INR | 0.0% |
2015 Q4 | 208.92 Billion INR | 0.0% |
2014 Q1 | - INR | -100.0% |
2014 FY | 157.17 Billion INR | 17.27% |
2014 Q4 | 157.17 Billion INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 Q2 | 147.33 Billion INR | 0.0% |
2013 Q1 | - INR | -100.0% |
2013 FY | 134.03 Billion INR | 14.97% |
2013 Q4 | 134.03 Billion INR | 0.0% |
2013 Q3 | - INR | -100.0% |
2013 Q2 | 131.78 Billion INR | 0.0% |
2012 FY | 116.57 Billion INR | 24.68% |
2012 Q4 | 116.57 Billion INR | 0.0% |
2011 FY | 93.5 Billion INR | 8.34% |
2010 FY | 86.3 Billion INR | 18.07% |
2009 FY | 73.09 Billion INR | 6.6% |
2008 FY | 68.56 Billion INR | 19.61% |
2007 FY | 57.32 Billion INR | 29.88% |
2006 FY | 44.13 Billion INR | 27.63% |
2005 FY | 34.58 Billion INR | 32.2% |
2004 FY | 26.16 Billion INR | 17.83% |
2003 FY | 22.2 Billion INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Abbott India Limited | 51.93 Billion INR | -529.978% |
Gland Pharma Limited | 106.61 Billion INR | -206.886% |
GlaxoSmithKline Pharmaceuticals Limited | 35.73 Billion INR | -815.503% |
Kopran Limited | 7.43 Billion INR | -4302.016% |
Marksans Pharma Limited | 26.8 Billion INR | -1120.38% |
NGL Fine-Chem Limited | 3.55 Billion INR | -9102.398% |
Pfizer Limited | 42.28 Billion INR | -673.694% |
Sanofi India Limited | 17.14 Billion INR | -1807.967% |
SMS Pharmaceuticals Limited | 10.34 Billion INR | -3063.916% |
TTK Healthcare Limited | 12 Billion INR | -2625.134% |